Corbus Pharmaceuticals Holdings (CRBP) 2025 Conference June 04, 2025 04:55 PM ET Speaker0 I take analyst in Maury Raycroft's team at Jefferies. I'm happy to introduce Yuval Cohen, CEO of Corbus. He's a fireside chat firm, so thank you for joining us today, Yuval. Speaker1 Thank you for having us here. Speaker0 So for those who may be new to the story, can you provide a one minute intro to Corbus? Sure. Speaker1 We are a drug discovery company or a direct development company. We're based just South Of Boston ...

TScan Therapeutics (TCRX) 2025 Conference June 04, 2025 04:55 PM ET Speaker0 My name is Rosenblatt with the Jefferies Investment Banking Team, and it is my pleasure to introduce you to Gavin Macbeth, Chief Executive Officer of T scan Therapeutics. Speaker1 Great. Thank you, and thank you to Jefferies for the opportunity to talk today. So as many of you know, we are a publicly traded company, so I will be making forward looking statements during this talk. So just by way of introduction, T scan is a fully in ...

BioCryst Pharmaceuticals (BCRX) 2025 Conference June 04, 2025 04:55 PM ET Speaker0 Hi, everyone. My name is Maury Raycrofton, one of the biotech analysts at Jefferies. With great pleasure, I'd like to welcome Helen Thackery, the Chief R and D Officer from BioChris. Thanks so much for joining us today, Helen. Speaker1 Thanks very much, Maury. Speaker0 And we're going to do a fireside chat discussion. So maybe to start off, for those who are unfamiliar with BioCryst, if you can set the stage and talk about Or ...

Allogene Therapeutics (ALLO) 2025 Conference June 04, 2025 04:55 PM ET Speaker0 We are very pleased to have the CEO of Allogene here with us, Doctor. David Chang. Allogene, despite the volatility of the markets, is obviously continuing to execute on the, I call it phase three, but pivotal phase two randomized study in a consolidation approach to first line DLBCL. And they have been working on that study, but also had some recent announcements on the last earnings. And so maybe it would be a good place to st ...

Kyverna Therapeutics (KYTX) 2025 Conference June 04, 2025 04:55 PM ET Speaker0 Good afternoon and welcome to Jefferies twenty twenty five Global Healthcare Conference. My name is Ashwin Serpaneini with the Jefferies Investment Banking team and it's my great pleasure to introduce Warner Biddle, CEO of Qiverna Therapeutics. Qiverna is focused on liberating patients through the curative potential of cell therapy. Its lead CAR T cell therapy candidate, KYV-one hundred one, is advancing through late stage clinic ...

Arthur J. Gallagher (AJG) Update / Briefing June 04, 2025 04:30 PM ET Speaker0 Good afternoon, and welcome to Arthur J. Gallagher and Company's Quarterly Investor Meeting with Management. Participants have been placed on a listen only mode. Your lines will be open for questions following the presentation. Today's call is being recorded. If you have any objections, you may disconnect at this time. Some of the comments made during this investor meeting, including answers given in response to questions, may co ...

Verastem (VSTM) 2025 Conference June 04, 2025 04:20 PM ET Speaker0 One of the biotech analysts are here. Please join me and welcome Mr. Dan Patterson, CEO from Verastem for this FerroSat chat session. Welcome, Dan. Speaker1 Thanks. Great to be here. Speaker0 And congratulations on the recent approval for low grade SARS ovarian cancer. Before we get into details, maybe you could give us a brief intro for the company Verastem and this novel combo, the recent approval and your interesting pipeline. Speaker1 Su ...

WEX (WEX) FY Conference June 04, 2025 04:20 PM ET Speaker0 I'm required to inform you that a complete list of research disclosures or potential conflicts of interest can be found on our website, williamblair.com. So with that, pleasure to introduce Melissa Smith, chairman and CEO of WEX as well as Steve Elder who runs the company's IR. And Melissa will walk us through a presentation. I expect we'll have time for a little bit of Q and A in this room and then there'll be a breakout session after. Speaker1 Tha ...

Verrica Pharmaceuticals Inc (VRCA) 2025 Conference June 04, 2025 04:20 PM ET Speaker0 Good afternoon. Welcome to day one of the Jefferies Healthcare Conference. My name is Dennis Ng, biotech analyst here at Jefferies. I have the great pleasure of having Verica Pharmaceuticals here with us. We have CEO Jason Rieger. Welcome. So why don't we kick things off with just a brief background and overview about the company, where you are today, and just kind of what's been happening over the last few years, just sor ...

Ingram Micro (INGM) FY Conference June 04, 2025 04:20 PM ET Speaker0 Thank you. Hi. Thank you all for joining. I'm Maggie Nolan. I'm the IT services analyst here at William Blair, and I cover a number of stocks including Ingram Micro. I'm required to inform you that for a complete list of research disclosures or potential conflicts of interest please visit our website at williamblair.com. So we're excited to have Ingram Micro with us today and to have the CFO Mike Zilis, thank you for joining us. He's going ...